PDE processing error related to NSDE file and edit 867
Guidance for All Part D Plan Sponsors regarding recent issue with the NSDE file that is causing a select few drugs to erroneously receive a rejection code of 867 – “FDA does not designate this drug as NDA or BLA, or this drug is a biosimilar drug; therefore it is ineligible for the coverage gap discount”.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 10, 2018
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.